<DOC>
	<DOCNO>NCT02033512</DOCNO>
	<brief_summary>There dilemma permanent debate side effect drug administer orally . The first-pass metabolism relate many side effect , since metabolite compound affect course human physiology . Conventional hormone therapy oral route use relieve menopausal symptom . Transdermal estrogen use extensively Brazilian woman menopausal symptomatology , however ; recently previous long term study indicate increase risk breast cancer vasomotor disorder menopausal woman , use transdermal HRT .</brief_summary>
	<brief_title>TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS</brief_title>
	<detailed_description>This prospective long-term clinical trial study female patient age 51-70 year old treat menopause relate hormone imbalance . Other result study publish elsewhere . Volunteers recruit referenced Gynecological Medical service patient chart maintain . This study prospective long-term clinical trial study randomize trial assess effect Transdermal HRT climacteric symptom hormone serum level early postmenopausal woman . Preliminary result trial , include first 42 woman enrol , publish ( 3 ) . In present analysis , 66 woman receive daily right left forearm transdermal nanostructured formulation Estriol ( 0.1 % ) + Estradiol ( 0.25 % ) Progesterone ( 10 % ) respectively ( Biolipid B2Â® , Evidence , SP , Brazil ) sixty month . The following compare : effect transdermal gel baseline THRT also analyze .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<criteria>1 ) last menstrual period 6 month 3 year begin study plus folliclestimulating hormone ( FSH ) level higher 35 IU/L ; 2 ) age 51 70 year ; 3 ) use medication know interfere hormonal level past 6 month . Patients present diabetes , previous hysterectomy , endometrial thickness high 5 mm , history cancer , thromboembolism establish cardio vascular disease exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>51 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Post-menopause</keyword>
	<keyword>Hormone Replacement Therapy</keyword>
	<keyword>Nanotechnology</keyword>
	<keyword>Biolipid B2</keyword>
</DOC>